4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001600132-16-000083
CIK 0001600132operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:10 PM ET
Size
5.4 KB
Accession
0001600132-16-000083
Insider Transaction Report
Form 4
Luehring Jens
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2016-06-17+10,000→ 10,000 totalExercise: $1.94Exp: 2026-06-16→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 17, 2016. This option vests in three equal annual installments over a three-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:10 PM ET
- Size
- 5.4 KB